Heart valve showdown: which device wins?
NCT ID NCT04443023
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two different artificial heart valves (Sapien and Myval) used in a procedure called TAVI to replace a narrowed aortic valve. Over 1,000 patients were randomly assigned to receive one of the two valves. The goal was to see which valve led to fewer major heart problems, like death, stroke, or valve issues, one year after the procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aarhus University Hospital
Aarhus, 8200, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI ultrasound could unmask silent heart disease in seniors
- Heart valve fix without the hospital stay? trial tests Same-Day discharge
- Can a wearable monitor prevent heart emergencies after valve replacement?
- Mountain air or heart risk? trial asks if high altitude is safe for aortic stenosis patients.
- Blood test could predict clot risk after heart valve surgery
- AI-Powered ultrasound could spot hidden heart valve disease in minutes